These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34310804)

  • 1. Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
    Ni Y; Yang Z; Agbana YL; Bai H; Wang L; Yang L; Yi Z; Cheng J; Zhang Q; Kuang Y; Zhu Y
    Cancer Sci; 2021 Oct; 112(10):4075-4086. PubMed ID: 34310804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
    Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
    Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
    [No Abstract]   [Full Text] [Related]  

  • 3. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
    Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
    Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
    Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
    Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
    Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
    J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
    He D; Yu Z; Liu S; Dai H; Xu Q; Li F
    Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
    Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
    Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
    Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
    J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.
    Xue YJ; Xiao RH; Long DZ; Zou XF; Wang XN; Zhang GX; Yuan YH; Wu GQ; Yang J; Wu YT; Xu H; Liu FL; Liu M
    J Transl Med; 2012 Sep; 10():200. PubMed ID: 23006512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
    Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
    Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma.
    Wang L; Wang J; Zhao H; Jiang G; Feng X; Sui W; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):551-563. PubMed ID: 30607469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00037 Inhibits Proliferation of Renal Cell Carcinoma Cells in an Epidermal Growth Factor Receptor-Dependent Way.
    Gong X; Du X; Xu Y; Zheng W
    Cell Physiol Biochem; 2018; 45(2):523-536. PubMed ID: 29393141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SIRT2 in Regulation of Stemness of Cancer Stem-Like Cells in Renal Cell Carcinoma.
    Wei R; He D; Zhang X
    Cell Physiol Biochem; 2018; 49(6):2348-2357. PubMed ID: 30261494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.